| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insight Molecular Diagnostics Inc. (IMDX) has 7 insiders with recent SEC Form 4 filings, including 16 buys and 5 sells. IMDX is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 12.68M | $69.01M | - | |
| CEO | 400.0K | $2.18M | - | |
| CFO | 201.2K | $1.09M | - | |
| Dir | 136.6K | $742.9K | - | |
| Dir | 39.5K | $214.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2022 | Pura Vida Investments, LLC | 10% Owner | Sell | 99,386 | $1.03 | $102,634.77 | -0.3% | -21.9% | -80.4% | |
| May 18, 2022 | Yu Li | VP Cntrllr/ Prncpl Acctng Offcr | Sale+OE | 8,128 | $1.14 | $9,265.92 | -32.5% | -19.6% | -77.7% | |
| Apr 14, 2022 | Pura Vida Investments, LLC | 10% Owner | Buy | 5,931,707 | $1.33 | $7,887,849.58 | +13.5% | -27.8% | -74.7% | |
| Apr 14, 2022 | Broadwood Partners, L.P.60 | 10% Owner | Buy | 6,003,752 | $1.33 | $7,999,999.54 | +14.7% | -27.8% | -74.7% | |
| Mar 25, 2022 | Ross Douglas T. | Chief Scientific Officer | Buy | 15,000 | $1.40 | $21,000.00 | +282.1% | -27.1% | -81.4% | |
| Mar 17, 2022 | Paulsen Gisela | Chief Operating Officer | Buy | 16,500 | $1.20 | $19,767.00 | New | -23.9% | -80.1% | |
| Mar 16, 2022 | Redmond Cavan M. | Director | Buy | 40,000 | $1.19 | $47,560.00 | +56.4% | -10.8% | -74.8% | |
| Mar 16, 2022 | Andrews Ronald Asbury | Chief Executive Officer | Buy | 50,000 | $1.28 | $64,150.00 | +20.6% | -10.8% | -74.8% | |
| Mar 15, 2022 | Levine Mitchell S | Chief Financial Officer | Buy | 25,000 | $1.17 | $29,150.00 | +40.3% | -2.6% | -82.6% | |
| Mar 19, 2021 | Andrews Ronald Asbury | Chief Executive Officer | Buy | 11,000 | $4.79 | $52,702.10 | +10.7% | +17.2% | -66.7% |